insulin glargine/lixisenatide fixed-ratio combination
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for insulin glargine/lixisenatide fixed-ratio combination, covering 2019-06-12 to 2022-07-19. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin [Phase 3]